666 related articles for article (PubMed ID: 31134496)
1. Heterogeneity and Plasticity of Breast Cancer Stem Cells.
Sousa B; Ribeiro AS; Paredes J
Adv Exp Med Biol; 2019; 1139():83-103. PubMed ID: 31134496
[TBL] [Abstract][Full Text] [Related]
2. Epithelial-mesenchymal plasticity of breast cancer stem cells: implications for metastasis and therapeutic resistance.
Luo M; Brooks M; Wicha MS
Curr Pharm Des; 2015; 21(10):1301-10. PubMed ID: 25506895
[TBL] [Abstract][Full Text] [Related]
3. Breast cancer stem cell: the roles and therapeutic implications.
Yang F; Xu J; Tang L; Guan X
Cell Mol Life Sci; 2017 Mar; 74(6):951-966. PubMed ID: 27530548
[TBL] [Abstract][Full Text] [Related]
4. Selective mode of action of plumbagin through BRCA1 deficient breast cancer stem cells.
Somasundaram V; Hemalatha SK; Pal K; Sinha S; Nair AS; Mukhopadhyay D; Srinivas P
BMC Cancer; 2016 May; 16():336. PubMed ID: 27229859
[TBL] [Abstract][Full Text] [Related]
5. Breast cancer stem cells transition between epithelial and mesenchymal states reflective of their normal counterparts.
Liu S; Cong Y; Wang D; Sun Y; Deng L; Liu Y; Martin-Trevino R; Shang L; McDermott SP; Landis MD; Hong S; Adams A; D'Angelo R; Ginestier C; Charafe-Jauffret E; Clouthier SG; Birnbaum D; Wong ST; Zhan M; Chang JC; Wicha MS
Stem Cell Reports; 2014 Jan; 2(1):78-91. PubMed ID: 24511467
[TBL] [Abstract][Full Text] [Related]
6. Targeting Breast Cancer Stem Cells.
Zhang L; Chen W; Liu S; Chen C
Int J Biol Sci; 2023; 19(2):552-570. PubMed ID: 36632469
[TBL] [Abstract][Full Text] [Related]
7. Modeling of Cancer Stem Cell State Transitions Predicts Therapeutic Response.
Sehl ME; Shimada M; Landeros A; Lange K; Wicha MS
PLoS One; 2015; 10(9):e0135797. PubMed ID: 26397099
[TBL] [Abstract][Full Text] [Related]
8. Breast cancer stem cells: Multiple capacities in tumor metastasis.
Geng SQ; Alexandrou AT; Li JJ
Cancer Lett; 2014 Jul; 349(1):1-7. PubMed ID: 24727284
[TBL] [Abstract][Full Text] [Related]
9. Cancer stem cells in solid and liquid tissues of breast cancer patients: characterization and therapeutic perspectives.
Chiotaki R; Polioudaki H; Theodoropoulos PA
Curr Cancer Drug Targets; 2015; 15(3):256-69. PubMed ID: 25669721
[TBL] [Abstract][Full Text] [Related]
10. Breast cancer stem cells: obstacles to therapy.
Smalley M; Piggott L; Clarkson R
Cancer Lett; 2013 Sep; 338(1):57-62. PubMed ID: 22554712
[TBL] [Abstract][Full Text] [Related]
11. WNT pathway inhibitor pyrvinium pamoate inhibits the self-renewal and metastasis of breast cancer stem cells.
Xu L; Zhang L; Hu C; Liang S; Fei X; Yan N; Zhang Y; Zhang F
Int J Oncol; 2016 Mar; 48(3):1175-86. PubMed ID: 26781188
[TBL] [Abstract][Full Text] [Related]
12. SURVIVIN as a marker for quiescent-breast cancer stem cells-An intermediate, adherent, pre-requisite phase of breast cancer metastasis.
Siddharth S; Das S; Nayak A; Kundu CN
Clin Exp Metastasis; 2016 Oct; 33(7):661-75. PubMed ID: 27411340
[TBL] [Abstract][Full Text] [Related]
13. Biological and clinical significance of cancer stem cell plasticity.
Zhu Y; Luo M; Brooks M; Clouthier SG; Wicha MS
Clin Transl Med; 2014 Dec; 3(1):32. PubMed ID: 26932376
[TBL] [Abstract][Full Text] [Related]
14. Breast cancer stem cells: current advances and clinical implications.
Luo M; Clouthier SG; Deol Y; Liu S; Nagrath S; Azizi E; Wicha MS
Methods Mol Biol; 2015; 1293():1-49. PubMed ID: 26040679
[TBL] [Abstract][Full Text] [Related]
15. Breast cancer stem cells and epithelial mesenchymal plasticity - Implications for chemoresistance.
Pinto CA; Widodo E; Waltham M; Thompson EW
Cancer Lett; 2013 Nov; 341(1):56-62. PubMed ID: 23830804
[TBL] [Abstract][Full Text] [Related]
16. Elimination of epithelial-like and mesenchymal-like breast cancer stem cells to inhibit metastasis following nanoparticle-mediated photothermal therapy.
Paholak HJ; Stevers NO; Chen H; Burnett JP; He M; Korkaya H; McDermott SP; Deol Y; Clouthier SG; Luther T; Li Q; Wicha MS; Sun D
Biomaterials; 2016 Oct; 104():145-57. PubMed ID: 27450902
[TBL] [Abstract][Full Text] [Related]
17. A preliminary study of the role of extracellular -5'- nucleotidase in breast cancer stem cells and epithelial-mesenchymal transition.
Yu J; Liao X; Li L; Lv L; Zhi X; Yu J; Zhou P
In Vitro Cell Dev Biol Anim; 2017 Feb; 53(2):132-140. PubMed ID: 27670764
[TBL] [Abstract][Full Text] [Related]
18. Breast cancer stem cells: are we ready to go from bench to bedside?
Lin CY; Barry-Holson KQ; Allison KH
Histopathology; 2016 Jan; 68(1):119-37. PubMed ID: 26768034
[TBL] [Abstract][Full Text] [Related]
19. Epithelial, mesenchymal and hybrid epithelial/mesenchymal phenotypes and their clinical relevance in cancer metastasis.
Garg M
Expert Rev Mol Med; 2017 Mar; 19():e3. PubMed ID: 28322181
[TBL] [Abstract][Full Text] [Related]
20. Revisiting epithelial-mesenchymal transition in cancer metastasis: the connection between epithelial plasticity and stemness.
Liao TT; Yang MH
Mol Oncol; 2017 Jul; 11(7):792-804. PubMed ID: 28649800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]